Global Next Generation Cancer Diagnostics Market By Product Type (Liquid Biopsy, Genetic Testing, Next Generation Sequencing, Immunoassays, and Radiomics), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Leukemia), By End-user (Hospitals, Research Institutions, Laboratories, and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Feb 2025
- Report ID: 140727
- Number of Pages: 235
- Format:
-
keyboard_arrow_up
-
-
- Thermo Fisher Scientific Company Profile
- QIAGEN NV Company Profile
- Novartis AG Company Profile
- Illumina, Inc
- GE HealthCare
- Hoffmann-La Roche Ltd
- Agilent Technologies, Inc
- Abbott Laboratories
- settingsSettings
Our Clients
- 140727
- Feb 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
